Fructose-Bisphosphate Aldolase: A Key Enzyme in Fructose Metabolism

Target Name: Fructose-Bisphosphate Aldolase

NCBI ID: P11284

Fructose-Bisphosphate Aldolase

Other Name(s): None

Fructose-Bisphosphate Aldolase: A Key Enzyme in Fructose Metabolism

Fructose-Bisphosphate Aldolase (FBAldolase) is an enzyme that is involved in the metabolism of fructose, which is a type of sugar that is found in fruits and some dairy products. This enzyme is a key player in the breakdown of fructose into its component parts , and it is involved in a wide range of physiological processes in the body.

FBAldolase is a protein that is expressed in many different tissues throughout the body, including the liver, pancreas, and muscle. It is a member of the alkaline phosphatase family, which includes a group of enzymes that play a key role in the regulation of calcium and phosphate homeostasis.

One of the unique features of FBAldolase is its ability to catalyze the breakdown of fructose into its component parts. This process involves the formation of a two-carbon compound called fructose 6-phosphate (6-PG), which is then converted into the simpler sugar molecule glucose.

FBAldolase is also involved in the regulation of the levels of calcium and phosphate in the body. It does this by catalyzing the breakdown of Ca2+-ATPase, which is a protein that helps to regulate the movement of calcium ions into and out of cells. This is important for maintaining the proper balance of calcium and phosphate in the body, which is essential for many different physiological processes.

In addition to its role in the metabolism of fructose, FBAldolase is also a potential drug target. Researchers are interested in using FBAldolase as a target for new treatments for a variety of diseases, including cancer, because of its ability to regulate the levels of calcium and phosphate in the body.

One way that researchers are exploring the potential of FBAldolase as a drug target is by using it to treat cancer. Studies have shown that inhibiting the activity of FBAldolase can lead to a reduction in the growth of cancer cells. This is because FBAldolase plays a key role in the metabolism of fructose, which is a common sugar found in many fruits and dairy products. By inhibiting the activity of FBAldolase, researchers may be able to limit the growth of cancer cells that are dependent on this sugar for their growth and survival.

Another potential use for FBAldolase as a drug target is in the treatment of osteoporosis. Osteoporosis is a condition in which the bones become weak and fragile due to a loss of bone mass. FBAldolase is involved in the regulation of bone growth and development, and researchers are interested in using it to treat osteoporosis by inhibiting its activity.

FBAldolase is also being studied as a potential biomarker for some diseases. For example, some researchers are interested in using FBAldolase as a diagnostic marker for osteoporosis, because of its ability to predict the risk of this disease. They are also exploring the potential of FBAldolase as a biomarker for cancer, because of its involvement in the regulation of calcium and phosphate homeostasis.

Overall, Fructose-Bisphosphate Aldolase (FBAldolase) is an important enzyme that is involved in the metabolism of fructose. It is also a potential drug target and biomarker, and its study is being closely monitored by researchers. Further research is needed to fully understand the role of FBAldolase in the body and its potential as a treatment for a variety of diseases.

Protein Name: Fructose-Bisphosphate Aldolase (nonspecified Subtype)

The "Fructose-Bisphosphate Aldolase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Fructose-Bisphosphate Aldolase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets